Application
18277886 · TOPICAL FORMULATIONS OF A JAK 1/3 INHIBITOR AND METHODS OF USE THEREOF FOR TREATMENT OF ATOPIC DERMATITIS AND OTHER SKIN CONDITIONS
Filed 2023-08-18 · Pending The official file ↗ · Art unit 1611 · Examiner Craig D Ricci Easy · CPC A61K 31/4545 · ACLARIS THERAPEUTICS, INC. · DLA Piper LLP (US)/Pittsburgh
Office actions
1
first was Restriction requirement
RCEs
0
no appeal
To first action
29.2 mo
to disposition n/a
Statutes raised
103 DP
1 actions read